FDA Center for Drug Evaluation & Research Issues Warning Letter to Foshan Miwei Cosmetics
April 29, 2026
April 29, 2026
WASHINGTON, April 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Foshan Miwei Cosmetics Co. Ltd. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Zhong Muqi, Chief Executive Officer, Foshan Miwei Cosmetics Co., Ltd., 801 & 802, Building 9, Baofa Jewellry Industry Centre, No. 1 Feicui Road, Yang'e Village Committee, Lunjiao Town, Shunde Qu Foshan Shi Guangdong Sheng . . .
* * *
Recipient: Mr. Zhong Muqi, Chief Executive Officer, Foshan Miwei Cosmetics Co., Ltd., 801 & 802, Building 9, Baofa Jewellry Industry Centre, No. 1 Feicui Road, Yang'e Village Committee, Lunjiao Town, Shunde Qu Foshan Shi Guangdong Sheng . . .